Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.2826 | 0 | 0.5 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.6974 | 1 | 1 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.6974 | 1 | 0.5 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.6974 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.6974 | 1 | 0.5 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.6974 | 1 | 0.5 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.6974 | 1 | 0.5 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.6974 | 1 | 0.5 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.6974 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | > 50 ug ml-1 | Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis assessed as growth inhibition at 0.3125 to 5 ug/mL by resazurin assay | ChEMBL. | 23942420 |
MIC (functional) | = 128 ug ml-1 | Antibacterial activity against Escherichia coli assessed as growth inhibition by serial dilution method | ChEMBL. | 23942420 |
MIC (functional) | = 256 ug ml-1 | Antifungal activity against Candida albicans assessed as growth inhibition by serial dilution method | ChEMBL. | 23942420 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.